Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Drug development research
- Publicado em
- 28 abr 2023
- Citações
- 10
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review
Hongmei Wang, Xuefeng Shan, Yang Peng, Weiying Zhou
Descritores MeSH
- MicroRNAs
- Triple Negative Breast Neoplasms
- Fluorouracil
- Humans
- Biomarkers
- RNA, Circular
- Drug Resistance, Neoplasm
- Phosphatidylinositol 3-Kinases
- Gene Expression Regulation, Neoplastic
- Doxorubicin
Veja também
Estudos relacionados
- Exosomal Non-Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications
- Non-Coding RNA-Based Therapeutic Strategies in Triple-Negative Breast Cancer: A Systematic Review
- Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200/205: A systematic review
- Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review